Aarti Drugs Legal & Regulatory
Aarti Drugs disclosed that the Supreme Court dismissed the GST Department's Special Leave Petition, effectively disposing of the tax litigation matter in the company's favor.
- Value
- ₹230.7 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Aarti Drugs disclosed that the Supreme Court dismissed the GST Department's Special Leave Petition, effectively disposing of the tax litigation matter in the company's favor.
The Supreme Court dismissed the GST Department's Special Leave Petition, favoring the company. This favorable order resolves the pending tax litigation regarding GST demands.
Aarti Drugs Limited received a revocation order from the GPCB for its Sayakha plant, allowing continued operations. The company paid Rs. 0.102 Crore as interim compensation.